CA Patent

CA2584655A1 — Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating inflammatory bowel disease

Assigned to Aventis Pharmaceuticals Inc · Expires 2006-04-27 · 20y expired

What this patent protects

The invention relates to the use of formula (I) in treating patients for the symptoms of inflammatory bowel disease including Crohn's disease and ulcerative colitis.

USPTO Abstract

The invention relates to the use of formula (I) in treating patients for the symptoms of inflammatory bowel disease including Crohn's disease and ulcerative colitis.

Drugs covered by this patent

Patent Metadata

Patent number
CA2584655A1
Jurisdiction
CA
Classification
—
Expires
2006-04-27
Drug substance claim
No
Drug product claim
No
Assignee
Aventis Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.